Cariprazine-d6

• CAT Number: S000300
• CAS Number: 1308278-67-2
• Molecular Formula: C21H26D6Cl2N4O
• Molecular Weight: 433.45
• Purity: ≥95%
• Target: Neuronal Signaling
• IUPAC Name: 3-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-1,1-bis(trideuteriomethyl)urea
• InChI: InChI=1S/C21H32Cl2N4O/c1-25(2)21(28)24-17-8-6-16(7-9-17)10-11-26-12-14-27(15-13-26)19-5-3-4-18(22)20(19)23/h3-5,16-17H,6-15H2,1-2H3,(H,24,28)/i1D3,2D3
• InChIKey: KPWSJANDNDDRMB-WFGJKAKNSA-N
• SMILES: CN(C)C(=O)NC1CCC(CC1)CCN2CCN(CC2)C3=C(C(=CC=C3)Cl)Cl

Cariprazine-d6（Cat No.:S000300） is a deuterated form of cariprazine, where six hydrogen atoms are replaced with deuterium, enhancing its molecular stability and making it valuable as an internal standard for analytical purposes like mass spectrometry and NMR spectroscopy. Cariprazine is an antipsychotic medication used primarily for treating schizophrenia and bipolar disorder. It works by balancing dopamine and serotonin levels in the brain. The incorporation of deuterium into cariprazine-d6 allows for more accurate pharmacokinetic and metabolic studies, providing clearer insights into the drug’s absorption, distribution, metabolism, and excretion processes in the body.